A role for opioid system in the proconvulsant effects of sildenafil on the pentylenetetrazole-induced clonic seizure in mice

Seizure

Volumn 20, Issue 5, 2011, Pages 409-413

  Montaser Kouhsari, Laleh ^a   Payandemehr, Borna ^a   Gholipour, Taha ^a   Ziai, Pouya ^a   Nabavizadeh, Pooneh ^a   Ghasemi, Abbas ^a   Bahremand, Arash ^a   Ghasemi, Mehdi ^a,b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clonic seizure threshold; Cyclic guanosine monophosphate (cGMP); Mice; Morphine; Naltrexone; Pentylenetetrazole; Sildenafil

Indexed keywords

BICUCULLINE; MORPHINE SULFATE; NALTREXONE; OPIATE RECEPTOR; PENTETRAZOLE; SILDENAFIL;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROCONVULSANT EFFECT; SEIZURE; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MICE; MORPHINE; OPIOID PEPTIDES; PENTYLENETETRAZOLE; PIPERAZINES; PURINES; SEIZURES; SULFONES;

EID: 79955698518     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2011.01.014     Document Type: Article

References (45)

1. Pyne NJ, Arshvsky V, Lochhead A. cGMP signal termination. Biochem Soc Trans 1996;24:1019-22.
2. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-45.
3. Corbin JD, Beasley A, Blount MA, Francis SH. Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5). Neurochem Int 2004;45:859-63. (Pubitemid 39108058)
4. Ambriz-Tututi M, Velazquez-Zamora DA, Urquiza-Marin H, Granados-Soto V. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. Eur J Pharmacol 2005;512:121-7. (Pubitemid 40544345)
5. Bezerra MM, Lima V, Girao VC, Teixeira RC, Graca JR. Antinociceptive activity of sildenafil and adrenergic agents in the writhing test in mice. Pharmacol Rep 2008;60:339-44.
6. Gilad R, Lampl Y, Eshel Y, Sadeh M. Tonic-clonic seizures in patients taking sildenafil. BMJ 2002;325:869. (Pubitemid 35215259)
7. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, Dehpour AR. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol 2006;147:935-43.
8. Lauretti GR, Ahmad I, Pleuvry BJ. The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology 1994;33:155-60.
9. Foote F, Gale K. Proconvulsant effect of morphine on seizures induced by pentylenetetrazol in the rat. Eur J Pharmacol 1984;105:179-84. (Pubitemid 14006351)
10. Homayoun H, Khavandgar S, Namiranian K, Gaskari SA, Dehpour AR. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res 2002;48:33-41. (Pubitemid 34127715)
11. Cowan A, Geller EB, Adler MW. Classification of opioids on the basis of change in seizure threshold in rats. Science 1979;206:465-7. (Pubitemid 10241245)
12. Mannino RA, Wolf HH. Opiate receptor phenomenon: proconvulsant action of morphine in the mouse. Life Sci 1974;15:2089-96.
13. Homayoun H, Khavandgar S, Zarrindast MR. Effects of adenosine receptor agonists and antagonists on pentylenetetrazole-induced amnesia. Eur J Pharmacol 2001;430:289-94. (Pubitemid 33050052)
14. Gholipour T, Riazi K, Noorian AR, Jannati A, Honar H, Doratotaj B, et al. Seizure susceptibility alteration following reversible cholestasis in mice: modulation by opioids and nitric oxide. Eur J Pharmacol 2008;580:322-8.
15. Honar H, Riazi K, Homayoun H, Sadeghipour H, Rashidi N, Ebrahimkhani MR, et al. Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures. Neuroscience 2004;129:733-42. (Pubitemid 39487124)
16. Kurt M, Bilge SS, Aksoz E, Kukula O, Celik S, Kesim Y. Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol 2004;56:353-7. (Pubitemid 39010771)
17. Loscher W, Honack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res 1991;8:171-89.
18. Foote F, Gale K. Morphine potentiates seizures induced by GABA antagonists and attenuates seizures induced by electroshock in the rat. Eur J Pharmacol 1983;95:259-64. (Pubitemid 14221363)
19. Shafaroodi H, Asadi S, Sadeghipour H, Ghasemi M, Ebrahimi F, Tavakoli S, et al. Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice. Epilepsy Res 2007;75:63-9. (Pubitemid 46856121)
20. Khavandgar S, Homayoun H, Dehpour AR. Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice. Pharmacol Biochem Behav 2003;74:795-801. (Pubitemid 36355946)
21. Pavone F, Castellano C, Oliverio A. Strain-dependent effects of shock-induced release of opioids: dissociation between analgesia and behavioral seizures. Brain Res 1986;366:326-8. (Pubitemid 16143830)
22. Wikler A, Altschul S. Effects of methadone and morphine of the electroencephalogram of the dog. J Pharmacol Exp Ther 1950;98:437-46.
23. Roshanpour M, Ghasemi M, Riazi K, Rafiei-Tabatabaei N, Ghahremani MH, Dehpour AR. Tolerance to the anticonvulsant effect of morphine in mice: blockage by ultra-low dose naltrexone. Epilepsy Res 2009;83:261-4.
24. Moreland RB, Goldstein II, Kim NN, Traish A. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endocrinol Metab 1999;10:97-104.
25. Ghasemi M, Sadeghipour H, Shafaroodi H, Nezami BG, Gholipour T, Hajrasouliha AR, et al. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. Br J Pharmacol 2007;151:591-601. (Pubitemid 47016299)
26. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science 1992;257:401-3.
27. Baggott J, Singh AN. Sildenafil-induced relapse in bipolar disorder: is nitric oxide the mechanism? Int J Neuropsychopharmacol 2004;7:525.
28. Milman HA, Arnold SB. Neurologic psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 2002;36:1129-34. (Pubitemid 34755786)
29. Jain NK, Patil CS, Singh A, Kulkarni SK. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001;909:170-8. (Pubitemid 32710130)
30. Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soto V. Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol 2000;400:81-7. (Pubitemid 30412112)
31. Asomoza-Espinosa R, Alonso-Lopez R, Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Torres-Lopez JE, Granados-Soto V. Sildenafil increases diclofenac antinociception in the formalin test. Eur J Pharmacol 2001;418:195-200. (Pubitemid 32441579)
32. Volke V, Wegener G, Vasar E. Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. J Physiol Pharmacol 2003;54:653-60. (Pubitemid 38029758)
33. Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 2008;18:323-32. (Pubitemid 351381351)
34. Dhir A, Kulkarni SK. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 2007;568:177-85. (Pubitemid 46976903)
35. Gholipour T, Rasouli A, Jabbarzadeh A, Nezami BG, Riazi K, Sharifzadeh M, et al. The interaction of sildenafil with the anticonvulsant effect of diazepam. Eur J Pharmacol 2009;617:79-83.
36. Nieoczym D, Socala K, Wlaz P. Lack of effect of sildenafil on cocaine-induced convulsions in mice. Pharmacol Rep 2009;61:930-4.
37. Nieoczym D, Luszczki JJ, Czuczwar SJ, Wlaz P. Effect of sildenafil on the anticonvulsant action of classical and second-generation antiepileptic drugs in maximal electroshock-induced seizures in mice. Epilepsia 2010;51:1552-9.
38. Nidhi G, Balakrishnan S, Pandhi P. Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods Find Exp Clin Pharmacol 1999;21:609-12. (Pubitemid 30033070)
39. Stefano GB, Salzet B, Rialas CM, Pope M, Kustka A, Neenan K, et al. Morphine-and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 1997;763:63-8. (Pubitemid 27323739)
40. Dortch-Carnes J, Randall KR. Morphine-induced nitric oxide production in isolated, iris-ciliary bodies. Exp Eye Res 2009;89:660-4.
41. Liu Y, Shenouda D, Bilfinger TV, Stefano ML,Magazine HI, Stefano GB. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res 1996;722:125-31. (Pubitemid 26202931)
42. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, et al. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 1999;11:189-93. (Pubitemid 29185137)
43. Lufty K, Woodward RM, Keana JF, Weber E. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011. Eur J Pharmacol 1994;252:261-6. (Pubitemid 24053693)
44. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron 1992;8:653-62.
45. Nieoczym D, Socala K, Rundfeldt C, Wlaz P. Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in rats. Pharmacol Rep 2010;62:383-91.